Table 3.
Revision Indications in Early and Later Discharge Aseptic Revision TJAs.
| Indication | Total |
Early DC Cases |
Later DC Cases |
P Value | |||
|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | ||
| THA revisions | |||||||
| ALTR | 31 | 24.8% | 17 | 31.5% | 14 | 20.0% | .008 |
| Component malposition | 5 | 4.0% | 5 | 9.3% | 0 | 0.0% | |
| Instability | 24 | 19.2% | 13 | 24.1% | 11 | 15.7% | |
| Loosening | 50 | 40.0% | 16 | 29.6% | 34 | 48.6% | |
| Osteolysis/polyethylene wear | 12 | 9.6% | 2 | 3.7% | 10 | 14.3% | |
| Other | 3 | 2.4% | 1 | 1.9% | 1 | 1.4% | |
| Total | 125 | 100.0% | 54 | 100.0% | 70 | 100.0% | |
| TKA revisions | |||||||
| Arthrofibrosis | 21 | 8.7% | 16 | 12.4% | 5 | 4.5% | .152 |
| Component malposition | 3 | 1.2% | 1 | 0.8% | 2 | 1.8% | |
| Instability | 115 | 47.7% | 65 | 50.4% | 50 | 44.6% | |
| Loosening | 83 | 34.4% | 37 | 28.7% | 46 | 41.1% | |
| Osteolysis/polyethylene wear | 14 | 5.8% | 7 | 5.4% | 7 | 6.3% | |
| Other | 5 | 2.1% | 3 | 2.3% | 2 | 1.8% | |
| Total | 241 | 100.0% | 129 | 100.0% | 112 | 100.0% | |
ALTR, adverse local tissue reaction; DC, discharge; TJA, total joint arthroplasty; THA, total hip arthroplasty; TKA, total knee arthroplasty.